Refining the Shared Decision Making Process Survey in ADHD Medication Decisions
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT05048186|
Recruitment Status : Completed
First Posted : September 17, 2021
Last Update Posted : September 17, 2021
|Condition or disease||Intervention/treatment|
|ADHD||Behavioral: Attention Deficit Hyperactivity Disorder Treatment Decision Aid|
This is a retrospective observational survey study. We will survey a sample of adult parents or legal guardians who have a child who has been diagnosed with Attention Deficit Hyperactivity Disorder (ADHD) and who discussed ADHD treatment options for their child with a health care provider within the last 2 years. The main goal is to gather evidence of the validity and reliability of the Shared Decision Making Process scale. Secondary goal is to gather evidence on the quality of decisions parents make about their children with ADHD. A third goal is to assess the impact of a Decision Aid on participant knowledge of ADHD treatment options. Participants will be randomized to one of two arms: participants in the intervention arm will review a Decision Aid (patient educational tool) partway through the survey and those in the control arm will not receive any educational materials. All participants will complete survey that includes the Shared Decision Making process survey along with a few other measures. A subset of respondents will also complete a retest survey about two weeks after the initial survey.
Study staff are working with a national sampling firm to recruit subjects and obtain 500 responses. The sample size was determined to ensure 80% power to detect difference of 0.25SD at 0.05 significant between intervention and control arm on participant knowledge scores. The decision aid intervention consists of a set of pre-visit summary cards for parents that cover the different treatment options and was developed by the Cincinnati Children's Hospital Medical Center.
For the analyses, study staff will examine the descriptives of the Shared Decision Making Process items and knowledge scores for the two arms. Study staff will examine rates of missing data to determine acceptability, and will examine descriptive results to see whether the scores span the range of total possible scores, are normally distributed, and whether there is evidence of floor or ceiling effects. Study staff will also test several hypotheses to examine validity of the scores such as whether higher shared decision making process scores are associated with less decisional conflict and less regret. Staff will also examine retest reliability of the Shared Decision Making Process scale.
|Study Type :||Observational|
|Actual Enrollment :||512 participants|
|Official Title:||Refining the Shared Decision Making Process Survey in ADHD Medication Decisions|
|Actual Study Start Date :||February 24, 2021|
|Actual Primary Completion Date :||March 23, 2021|
|Actual Study Completion Date :||April 13, 2021|
Decision Aid Arm
Participants in this arm will review educational material from the ADHD Decision Aid developed by the Cincinnati Children's Hospital Medical Center.
Behavioral: Attention Deficit Hyperactivity Disorder Treatment Decision Aid
The parent pre-visit cards from the Cincinnati Children's Hospital's Attention Deficit Hyperactivity Disorder (ADHD) Treatment for School Age Children Decision Aid were used in this study. The 6 pre-visit cards provide an overview of ADHD treatment options, the respective benefits and downsides of each option, and questions to elicit goals/preferences. The four different treatment options presented were: (1) watchful waiting, (2) behavioral treatment, (3) medication treatment, and (4) combined treatment (behavioral and medication together).
Participants in this group will not receive any educational materials.
- Shared Decision Making Process score [ Time Frame: baseline survey, up to 24 months ]The Shared Decision Making Process scale is a short patient-reported survey that measures the amount of shared decision making that occurs in an interaction. Scores range from 0-4 where higher values indicate a better shared decision making process occurred.
- ADHD Knowledge [ Time Frame: baseline survey, up to 24 months ]Multiple choice knowledge items are scored correct/incorrect and a total knowledge score (0-100%) is calculated with higher scores indicating higher knowledge.
- Decisional Conflict tool (SURE) [ Time Frame: baseline survey, up to 24 months ]Measures decisional conflict, consists of 4 yes/no items. Scores range 0-4 where 0 indicates extremely high decisional conflict, 0 indicates no decisional conflict, and scores less than or equal to 3 indicate decisional conflict.
- Single-item Measure of Decision Regret [ Time Frame: baseline survey, up to 24 months ]
Single item asking "If you knew then what you know now, do you think you would make the same decision.
Response options are:
Definitely yes, Probably yes, Probably no, Definitely no.
- Treatment choice [ Time Frame: baseline survey, up to 24 months ]3 items that asked parents how they wanted to treat their child's ADHD. Items allowed parents to choose more than one type of treatment option.
- National Initiative for Children's Healthcare Quality (NICHQ) Vanderbilt Assessment Performance sub-scale [ Time Frame: baseline survey, up to 24 months ]8 items that ask parents to rate their child's performance in school overall, in individual subjects such as reading, relationships with others such as parents and peers, and their participation in organized activities. There were 5 response options: Excellent, above average, average, somewhat of a problem, and problematic
- Adapted Controlled Preference Scale [ Time Frame: baseline survey, up to 24 months ]Single item asking the parent who made the ultimate decision. The categorical response options are 1) the parent made the decision, 2)the child's provider made the decision, 3) both parent and provider made the decision together
- Shared Decision Making Process Measure retest [ Time Frame: 2 weeks after completing the baseline survey ]The Shared Decision Making Process is a short patient-reported survey that measures the amount of shared decision making that occurs in an interaction. Scores range from 0-4 where higher values indicate a better shared decision making process occurred.
- Adherence [ Time Frame: baseline survey, up to 24 months ]1 item measure of adherence to medication for sample of participants who indicated their child was taking medicine
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05048186
|United States, Massachusetts|
|Massachusetts General Hospital|
|Boston, Massachusetts, United States, 02114|
|Principal Investigator:||Karen Sepucha, PhD||Massachusetts General Hospital|